Correction to NPS Hormone Drug Article on Friday
24 Janeiro 2015 - 8:40PM
Dow Jones News
NPS announced in December that the European Medicines Agency
validated its marketing authorization application and started its
review of the drug. "NPS Hormone Drug Gets FDA Approval," at 7:54
p.m. EST on Friday, misstated the drug got EMA approval in the
ninth paragraph.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Nps (NASDAQ:NPSP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Nps (NASDAQ:NPSP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de NPS Pharmaceuticals Inc.